This positive ruling for hygiene brands is a reminder that applicants must be cautious in adopting parts of registered marks, particularly if the identical part is at the beginning, as only differing the end-syllable is not a guarantee of preventing infringement.
The ASCI’s Annual Complaints Report 2023-2024 reveals crucial insights into brand advertising campaigns in India, with 98% of scrutinised ads requiring modification. Misleading ads present a challenge for law enforcement and brands must adhere to court rulings or else risk the suspension of their manufacturing licences.
In our latest round-up, we look at the adidas motion for a new Thom Browne trial being denied, an OtterBox counterfeit bust, and more.
An EU trademark challenge underlines the rules surrounding the submission of evidence of genuine use, in cases of late submission and the combined use of multiple marks.
23 August 2023
The fact that the applicant had applied to register a large number of trademarks for various goods and services did not suffice to prove that the contested trademark had been filed in bad faith.
04 August 2023
The reasoning provided by TÜRKPATENT in a recent case may serve as a guide when considering whether to raise bad faith as a ground for opposition.
19 July 2023
The WTR Brand Elite rose seven points through June, hitting its highest value since 1 February 2022.
18 July 2023
We complete our series highlighting recent Legal Updates that you may have missed by looking at cases where the EU General Court criticised the findings of the Board of Appeal of the EUIPO.
14 July 2023
The WTR Brand Elite dropped one point through May, as major stock indices returned mixed results. Tech brands performed strongly, with a suite of new AI-powered Alexa devices giving Amazon a notable boost.
22 June 2023
The decision sheds light on the criteria to be applied to the examination of composite trademarks.
08 June 2023
Glaxo has prevailed on appeal in these long-running invalidity proceedings, with the General Court annulling a EUIPO decision invalidating Glaxo’s 3D mark for the shape of an inhaler.
06 June 2023
Unlock unlimited access to all WTR content
